TY - JOUR
T1 - Prehospital antiplatelet use and functional status on admission of patients with non-haemorrhagic moyamoya disease
T2 - A nationwide retrospective cohort study ( J-ASPECT study)
AU - the J-ASPECT Study Collaborators
AU - Onozuka, Daisuke
AU - Hagihara, Akihito
AU - Nishimura, Kunihiro
AU - Kada, Akiko
AU - Nakagawara, Jyoji
AU - Ogasawara, Kuniaki
AU - Ono, Junichi
AU - Shiokawa, Yoshiaki
AU - Aruga, Toru
AU - Miyachi, Shigeru
AU - Nagata, Izumi
AU - Toyoda, Kazunori
AU - Matsuda, Shinya
AU - Suzuki, Akifumi
AU - Kataoka, Hiroharu
AU - Nakamura, Fumiaki
AU - Kamitani, Satoru
AU - Nishimura, Ataru
AU - Kurogi, Ryota
AU - Sayama, Tetsuro
AU - Iihara, Koji
PY - 2016
Y1 - 2016
N2 - Objectives: To elucidate the association between antiplatelet use in patients with non-haemorrhagic moyamoya disease before hospital admission and good functional status on admission in Japan. Design: Retrospective, multicentre, non-randomised, observational study. Setting: Nationwide registry data in Japan. Participants: A total of 1925 patients with nonhaemorrhagic moyamoya disease admitted between 1 April 2012 and 31 March 2014 in Japan. Main outcome measure: We performed propensity score-matched analysis to examine the association between prehospital antiplatelet use and no significant disability on hospital admission, as defined by a modified Rankin Scale score of 0 or 1. Results: Propensity-matched patients who received prehospital antiplatelet drugs were associated with a good outcome on hospital admission (OR adjusted for all covariates, 3.82; 95% CI 1.22 to 11.99) compared with those who did not receive antiplatelet drugs prior to hospital admission. Conclusions: Prehospital antiplatelet use was significantly associated with good functional status on hospital admission among patients with nonhaemorrhagic moyamoya disease in Japan. Our results suggest that prehospital antiplatelet use should be considered when evaluating outcomes of patients with non-haemorrhagic moyamoya disease.
AB - Objectives: To elucidate the association between antiplatelet use in patients with non-haemorrhagic moyamoya disease before hospital admission and good functional status on admission in Japan. Design: Retrospective, multicentre, non-randomised, observational study. Setting: Nationwide registry data in Japan. Participants: A total of 1925 patients with nonhaemorrhagic moyamoya disease admitted between 1 April 2012 and 31 March 2014 in Japan. Main outcome measure: We performed propensity score-matched analysis to examine the association between prehospital antiplatelet use and no significant disability on hospital admission, as defined by a modified Rankin Scale score of 0 or 1. Results: Propensity-matched patients who received prehospital antiplatelet drugs were associated with a good outcome on hospital admission (OR adjusted for all covariates, 3.82; 95% CI 1.22 to 11.99) compared with those who did not receive antiplatelet drugs prior to hospital admission. Conclusions: Prehospital antiplatelet use was significantly associated with good functional status on hospital admission among patients with nonhaemorrhagic moyamoya disease in Japan. Our results suggest that prehospital antiplatelet use should be considered when evaluating outcomes of patients with non-haemorrhagic moyamoya disease.
UR - http://www.scopus.com/inward/record.url?scp=84962563068&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84962563068&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2015-009942
DO - 10.1136/bmjopen-2015-009942
M3 - Article
C2 - 27008684
AN - SCOPUS:84962563068
SN - 2044-6055
VL - 6
JO - BMJ open
JF - BMJ open
IS - 3
M1 - e009942
ER -